AHR and lung carcinoma: Similarly, the AhRL benzo(a)pyrene (BaP) induced PD-L1 expression on lung epithelial cells and promoted lung cancer progression, while anti-PD-L1 antibodies or AhR deficiency suppressed BaP-induced lung cancer progression [102].